Home › Icagen Issued U.S. Patent Covering Diagnostic And Discovery Applications Of Its Proprietary XRpro X-Ray Fluorescence Technology
 

Keywords :   


Icagen Issued U.S. Patent Covering Diagnostic And Discovery Applications Of Its Proprietary XRpro X-Ray Fluorescence Technology

2016-06-01 06:00:52| drugdiscoveryonline Home Page

Icagen, Inc. recently announced that the U.S. Patent and Trademark Office has granted the company patent number 9,335,284 B2, “Methods for Analysis Using X-Ray Fluorescence,” covering applications of the company’s proprietary XRpro X-ray fluorescence technology to the development of biomarkers and diagnostics

Tags: technology applications issued patent

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »